FANJ
LJPC

Financial Architects (New Jersey)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Financial Architects (New Jersey)’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed – – 1594
2019
Q1 		$0 Hold
50
– – ﹤0.01% 1604
2018
Q4 		$0 Hold
50
– – ﹤0.01% 1592
2018
Q3 		$1K Hold
50
– – ﹤0.01% 1402
2018
Q2 		$1K Sell
50
-20
-29% -$617 ﹤0.01% 1311
2018
Q1 		$2K Hold
70
– – ﹤0.01% 1343
2017
Q4 		$2K Sell
70
-80
-53% -$2.61K ﹤0.01% 1438
2017
Q3 		$5K Sell
150
-250
-63% -$8.04K ﹤0.01% 1294
2017
Q2 		$12K Buy
+400
New +$11.5K ﹤0.01% 1101

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Financial Architects (New Jersey)'s LJPC Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 50 shares.

Financial Architects (New Jersey) first reported a position in LJPC in Q2 2017 and held it in 8 quarters. The position peaked at $12K in Q2 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 50 La Jolla Pharmaceutical Company shares in Q2 2019.
  • Financial Architects (New Jersey) first reported a position in La Jolla Pharmaceutical Company in Q2 2017 and held it in 8 quarters.
  • Financial Architects (New Jersey)'s La Jolla Pharmaceutical Company position peaked at $12K in Q2 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.